PLIVA Announces Approval for Citalopram Hydrobromide Tablets

08-Nov-2005

PLIVA d.d. announced that PLIVA Inc., its US generics subsidiary, has received final approval from the U.S. food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Citalopram Hydrobromide Tablets 10 mg, 20 mg, and 40 mg. Citalopram Hydrobromide is the AB-rated generic equivalent of Forest Laboratories' Celexa, from a class of medications called selective serotonin reuptake inhibitors (SSRIs), used for the treatment of depression.

Other news from the department research and development

Most read news

More news from our other portals

Discover the latest developments in battery technology!